These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17547524)

  • 21. Can cancer be diagnosed with a blood test during routine examinations?
    Weiss PA; Weiss PA
    Clin J Oncol Nurs; 2007 Dec; 11(6):940-1. PubMed ID: 18063553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence.
    Havrilesky LJ; Whitehead CM; Rubatt JM; Cheek RL; Groelke J; He Q; Malinowski DP; Fischer TJ; Berchuck A
    Gynecol Oncol; 2008 Sep; 110(3):374-82. PubMed ID: 18584856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarkers for cancer risk, early detection, and prognosis: the validation conundrum.
    Brenner DE; Normolle DP
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1918-20. PubMed ID: 17932336
    [No Abstract]   [Full Text] [Related]  

  • 24. Diagnostic markers for early detection of ovarian cancer.
    Visintin I; Feng Z; Longton G; Ward DC; Alvero AB; Lai Y; Tenthorey J; Leiser A; Flores-Saaib R; Yu H; Azori M; Rutherford T; Schwartz PE; Mor G
    Clin Cancer Res; 2008 Feb; 14(4):1065-72. PubMed ID: 18258665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Model program for screening oral cancers in the Roma population].
    Csépe P; Bánóczy J; Dombi C; Forrai J; Gyenes M; Döbrossy L
    Magy Onkol; 2007; 51(2):95-101. PubMed ID: 17660865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteomics-driven cancer biomarker discovery: looking to the future.
    Simpson RJ; Bernhard OK; Greening DW; Moritz RL
    Curr Opin Chem Biol; 2008 Feb; 12(1):72-7. PubMed ID: 18295612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteins' promise--progress and challenges in ovarian cancer proteomics.
    Koehn H; Oehler MK
    Menopause Int; 2007 Dec; 13(4):148-53. PubMed ID: 18088525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum biomarker profiling in cancer studies: a question of standardisation?
    Matharoo-Ball B; Miles AK; Creaser CS; Ball G; Rees R
    Vet Comp Oncol; 2008 Dec; 6(4):224-47. PubMed ID: 19178682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer screenings, diagnostic technology evolution, and cancer control.
    Stracci F
    Methods Mol Biol; 2009; 471():107-36. PubMed ID: 19109777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is prostate-specific antigen velocity useful in early detection of prostate cancer? A critical appraisal of the evidence.
    Etzioni RD; Ankerst DP; Weiss NS; Inoue LY; Thompson IM
    J Natl Cancer Inst; 2007 Oct; 99(20):1510-5. PubMed ID: 17925534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New blood-based biomarkers for the diagnosis, staging and prognosis of prostate cancer.
    Shariat SF; Karam JA; Margulis V; Karakiewicz PI
    BJU Int; 2008 Mar; 101(6):675-83. PubMed ID: 17941930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Identification of new ovarian cancer biomarkers with proteomic analyses--the diagnostic tool of the future?].
    Petri AL; Høgdall E; Engelholm SA; Christensen IJ; Kjaer SK; Høgdall CK
    Ugeskr Laeger; 2007 Aug; 169(33):2614-9. PubMed ID: 17725906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood biomarkers for prostate cancer detection and prognosis.
    Shariat SF; Karam JA; Roehrborn CG
    Future Oncol; 2007 Aug; 3(4):449-61. PubMed ID: 17661720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A need for basic research on fluid-based early detection biomarkers.
    Martin KJ; Fournier MV; Reddy GP; Pardee AB
    Cancer Res; 2010 Jul; 70(13):5203-6. PubMed ID: 20587531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multianalyte profiling of serum antigens and autoimmune and infectious disease molecules to identify biomarkers dysregulated in epithelial ovarian cancer.
    Bertenshaw GP; Yip P; Seshaiah P; Zhao J; Chen TH; Wiggins WS; Mapes JP; Mansfield BC
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2872-81. PubMed ID: 18843033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Found in transcription: gene expression and other novel blood biomarkers for the early detection of breast cancer.
    Lönneborg A; Aarøe J; Dumeaux V; Børresen-Dale AL
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1115-23. PubMed ID: 19671031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNAs are novel biomarkers of colorectal cancer.
    Aslam MI; Taylor K; Pringle JH; Jameson JS
    Br J Surg; 2009 Jul; 96(7):702-10. PubMed ID: 19526617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis.
    Yi JK; Chang JW; Han W; Lee JW; Ko E; Kim DH; Bae JY; Yu J; Lee C; Yu MH; Noh DY
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1357-64. PubMed ID: 19423516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How the measurements of a few serum markers can be combined to enhance their clinical values in the management of cancer.
    Cordero OJ; De Chiara L; Lemos-González Y; Páez de la Cadena M; Rodríguez-Berrocal FJ
    Anticancer Res; 2008; 28(4C):2333-41. PubMed ID: 18751415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.